#FdaApproval
AEON Biopharma CEO Rob Bancroft eases investors’ minds noting that ABP-450 is already approved by the FDA for aesthetic indications.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/7fQeo...
AEON Reassuring Investors
YouTube video by Unboxing Biotech
youtube.com
November 19, 2026 at 3:14 AM
Breaking: The FDA has approved Replimune's oncolytic immunotherapy for advanced melanoma, reversing two previous rejection decisions…

#Acceleratedapproval #Cancertreatment #FDAapproval #Melanoma #Oncolyticimmunotherapy

#Acceleratedapproval #Cancertreatment #FDAapproval #Melanoma #Oncolyticimmun…
FDA Approves Replimune Melanoma Treatment
Breaking: The FDA has approved Replimune's oncolytic immunotherapy for advanced melanoma, reversing two previous rejection decisions… #Acceleratedapproval #Cancertreatment #FDAapproval #Melanoma #Oncolyticimmunotherapy
news.gmj.ge
November 17, 2026 at 3:27 PM
✓ BREAKING: The FDA has approved Moderna's mRNA-1010, the first mRNA influenza vaccine—extending messenger RNA technology beyond COVID-19. While regulators ha…

#Biotechnology #FDAapproval #Influenzaimmunisation #Moderna #MRNAvaccine

#Biotechnology #FDAapproval #Influenzaimmunisation #Moderna #M…
FDA Approves First mRNA Flu Vaccine—What's Next?
✓ BREAKING: The FDA has approved Moderna's mRNA-1010, the first mRNA influenza vaccine—extending messenger RNA technology beyond COVID-19. While regulators ha… #Biotechnology #FDAapproval #Influenzaimmunisation #Moderna #MRNAvaccine
news.gmj.ge
November 17, 2026 at 9:27 PM
FDA approves giredestrant (Wilserdly), an all-oral combo for ESR1-mutated breast cancer www.humolyte.com/blog/giredes... #BreastCancer #FDAApproval #CancerNews #SupportiveCare
November 17, 2026 at 6:45 PM
The FDA has approved KLYGEFA (gefurulimab-gaks), a new treatment for adults with generalized myasthenia gravis (MG) who are positive for acetylcholine receptor (AChR) antibodies.

#MyastheniaGravis #GeneralizedMyastheniaGravis #Bionews #FDAApproval #MyastheniaGravisNews
November 16, 2026 at 7:10 PM
History of Botox
YouTube video by Unboxing Biotech
youtube.com
November 14, 2026 at 9:50 PM
Biocon Wins US FDA Approval for Pebrilzo Biosimilar to Perjeta Ahead of 2028 Launch

Biocon announced U.S. FDA approval on 16 November for Pebrilzo, its fifth oncology biosimilar, ahead of a Q3 2028 U.S. launch.

#Biocon #FDAApproval #Biosimilars
November 17, 2026 at 8:02 AM
FDA Approves Genentech's Gazyva for Primary Membranous Nephropathy Expanding Kidney Care

The U.S. FDA approved Genentech's Gazyva on 14 November for primary membranous nephropathy, expanding autoimmune kidney therapy.

#FDAApproval #Gazyva #Biotech
November 15, 2026 at 5:21 AM
The FDA (@fda.gov) has approved Enspryng® (satralizumab-mwge, Genentech) for the treatment of thyroid eye disease (TED) in adults, offering a new at-home subcutaneous treatment option.

Learn more: https://bit.ly/4pLR0O3

#ThyroidEyeDisease #FDAApproval #Ophthalmology #EyeCare
FDA Alerts: Ophthalmology Drug and Device Approvals
FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.
bit.ly
November 16, 2026 at 6:06 PM
The FDA (@fda.gov) has approved Enspryng® (satralizumab-mwge, Genentech) for the treatment of thyroid eye disease (TED) in adults, offering a new at-home subcutaneous treatment option.

Learn more: https://bit.ly/4qYjzbT

#ThyroidEyeDisease #FDAApproval #Optometry #EyeCare
FDA Alerts: New Optometry Drugs and Devices
This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.
bit.ly
November 16, 2026 at 6:09 PM
AEON Biopharma CEO Rob Bancroft shares some of the tools the FDA is using to evaluate biosimilarity.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/zT65k...
Tools to Evaluate Biosimilarity
YouTube video by Unboxing Biotech
youtube.com
November 9, 2026 at 11:34 PM
AEON Biopharma CEO Rob Bancroft explains the financial difficulties therapeutic providers face when using Botox.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/GiXzo...
Why Doctors Barely Profit from Botox
YouTube video by Unboxing Biotech
youtube.com
November 5, 2026 at 12:29 AM
The FDA approved bepirovirsen (Hibsago) following two phase 3 clinical trials published in the New England Journal of Medicine. It represents the first functional cure for chronic hepatitis B, suppressing the virus to undetectable levels and maintaining con…

#HepatitisB #FunctionalCure #FDAApproval
GSK unveils first functional cure for chronic hepatitis B
Source: ScienceAlert
realfeedapp.com
November 5, 2026 at 8:40 AM
AEON Biopharma CEO Rob Bancroft discusses the FDA-requested bridging studies for the head to head trials between ABP-450 and Botox.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/v9fel...
Botox Bridging Studies
YouTube video by Unboxing Biotech
youtube.com
October 31, 2026 at 8:12 PM
FDA approves first immunotherapy for advanced rectal cancer

beta.pharm2market.app?story=story-... #Oncology #Immunotherapy #FDAApproval #ClinicalTri
Pharm2Market | Business Intelligence for Biotechs
beta.pharm2market.app
October 29, 2026 at 3:35 PM
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial: FDA approval may be imminent for a key innovation in dentistry that could spare thousands of children from painful… @goodnewsnetwork.org #FDAApproval #CavityCare #DentalInnovation #OralHealth #ChildHealth
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial
FDA approval may be imminent for a key innovation in dentistry that could spare thousands of children from painful pulling, drilling, and infections with a simple fluid coating. Every year, untreated tooth decay sends thousands of young US children to emergency departments for dental problems doctors can’t treat. Many eventually undergo surgery under general anesthesia, […] The post FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial appeared first on Good News Network.
dlvr.it
October 28, 2026 at 2:14 AM
AEON Biopharma CEO Rob Bancroft summarizes ABP-450's analytical studies and other work completed so far to support biosimilarity.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/m05Lt...
ABP-450 Next Studies
YouTube video by Unboxing Biotech
youtube.com
October 26, 2026 at 12:24 AM
AEON Biopharma CEO Rob Bancroft underscores FDA feedback from Type 2a and 2b meetings.
#$AEON #BiotechStocks #Investing #BioTech #Biosimilars #Investors #ABP450 #BotoxBiosimilar #FDAApproval
youtube.com/shorts/WzoC-...
AEON s FDA Meetings
YouTube video by Unboxing Biotech
youtube.com
October 23, 2026 at 9:54 PM
www.newsmason.com
October 21, 2026 at 2:08 AM